{"hands_on_practices": [{"introduction": "The molecular initiating event for many endocrine disruptors is direct competition with endogenous hormones for receptor binding. This exercise explores the quantitative basis of this competition, governed by the laws of mass action. By deriving and applying the competitive binding model, you will see how a high environmental concentration of a low-affinity disruptor can lead to significant receptor occupancy, potentially displacing the natural ligand and altering cellular signaling.", "problem": "In a fetal mammalian gonad, the Estrogen Receptor (ER) is exposed simultaneously to the endogenous ligand 17β-estradiol (E2) and the endocrine disruptor bisphenol A (BPA). Assume a single class of non-cooperative binding sites, thermodynamic equilibrium, and that free ligand concentrations are well-approximated by their total concentrations. Let the total receptor concentration be $\\left[R_T\\right]$, the concentration of unbound receptor be $\\left[R\\right]$, and the concentration of receptor bound by ligand $i$ be $\\left[RL_i\\right]$. The dissociation constant for ligand $i$ is defined by the law of mass action as $K_{d,i}=\\dfrac{\\left[R\\right]\\left[L_i\\right]}{\\left[RL_i\\right]}$. Under assay conditions that stabilize receptor–ligand complexes, suppose the apparent dissociation constants are $K_{d,\\mathrm{E2}}=0.2$ nM and $K_{d,\\mathrm{BPA}}=2$ nM. The extracellular concentrations are $\\left[\\mathrm{E2}\\right]=0.1$ nM and $\\left[\\mathrm{BPA}\\right]=10$ nM.\n\nStarting only from the definition of $K_{d,i}$ and receptor conservation $\\left[R_T\\right]=\\left[R\\right]+\\sum_i \\left[RL_i\\right]$, derive an expression for the fractional occupancy $f_i=\\dfrac{\\left[RL_i\\right]}{\\left[R_T\\right]}$ of ER by each ligand $i\\in\\{\\mathrm{E2},\\mathrm{BPA}\\}$ in a competitive mixture, and then compute the numerical values of $f_{\\mathrm{E2}}$ and $f_{\\mathrm{BPA}}$ for the given parameters. Express your final answer as a row matrix $f_{\\mathrm{E2}} \\text{ and } f_{\\mathrm{BPA}}$ in decimal form without units, rounded to four significant figures. No percentages are permitted.", "solution": "The problem as stated is scientifically grounded, well-posed, objective, and internally consistent. It presents a standard competitive ligand-receptor binding scenario, a fundamental concept in pharmacology and endocrinology. All necessary constants, definitions, and initial conditions are provided to derive a unique, meaningful solution. Thus, the problem is valid and we may proceed with the derivation.\n\nThe objective is to derive an expression for the fractional occupancy, $f_i = \\frac{\\left[RL_i\\right]}{\\left[R_T\\right]}$, for two competing ligands, $17\\beta$-estradiol (E2) and bisphenol A (BPA), binding to the Estrogen Receptor (ER). We are to start only from the provided definitions.\n\nLet the ligands be indexed by $i$, where $i \\in \\{\\mathrm{E2}, \\mathrm{BPA}\\}$.\nThe system is governed by the law of mass action for each ligand at equilibrium:\n$$K_{d,i} = \\frac{\\left[R\\right]\\left[L_i\\right]}{\\left[RL_i\\right]}$$\nFrom this definition, we can express the concentration of receptor-ligand complex, $\\left[RL_i\\right]$, as a function of the unbound receptor concentration, $\\left[R\\right]$:\n$$\\left[RL_i\\right] = \\frac{\\left[R\\right]\\left[L_i\\right]}{K_{d,i}}$$\n\nThe second governing principle is the conservation of total receptor concentration, $\\left[R_T\\right]$. In a mixture with two ligands, this is:\n$$\\left[R_T\\right] = \\left[R\\right] + \\left[RL_{\\mathrm{E2}}\\right] + \\left[RL_{\\mathrm{BPA}}\\right]$$\n\nWe substitute the expression for each receptor-ligand complex into the conservation equation:\n$$\\left[R_T\\right] = \\left[R\\right] + \\frac{\\left[R\\right]\\left[\\mathrm{E2}\\right]}{K_{d,\\mathrm{E2}}} + \\frac{\\left[R\\right]\\left[\\mathrm{BPA}\\right]}{K_{d,\\mathrm{BPA}}}$$\n\nFactoring out the common term $\\left[R\\right]$ yields:\n$$\\left[R_T\\right] = \\left[R\\right] \\left( 1 + \\frac{\\left[\\mathrm{E2}\\right]}{K_{d,\\mathrm{E2}}} + \\frac{\\left[\\mathrm{BPA}\\right]}{K_{d,\\mathrm{BPA}}} \\right)$$\n\nThe fractional occupancy for a specific ligand $i$, $f_i$, is defined as $f_i = \\frac{\\left[RL_i\\right]}{\\left[R_T\\right]}$. We can substitute the expressions for both $\\left[RL_i\\right]$ and $\\left[R_T\\right]$:\n$$f_i = \\frac{\\frac{\\left[R\\right]\\left[L_i\\right]}{K_{d,i}}}{\\left[R\\right] \\left( 1 + \\frac{\\left[\\mathrm{E2}\\right]}{K_{d,\\mathrm{E2}}} + \\frac{\\left[\\mathrm{BPA}\\right]}{K_{d,\\mathrm{BPA}}} \\right)}$$\n\nThe concentration of unbound receptor, $\\left[R\\right]$, cancels from the numerator and denominator, which is expected as the fractional occupancy should not depend on $\\left[R\\right]$ itself, but on the relative concentrations and affinities of the ligands. The general expression for the fractional occupancy of ligand $i$ in a competitive mixture is therefore:\n$$f_i = \\frac{\\frac{\\left[L_i\\right]}{K_{d,i}}}{1 + \\sum_j \\frac{\\left[L_j\\right]}{K_{d,j}}}$$\nwhere the sum is over all ligands in the mixture.\n\nFor E2, this expression is:\n$$f_{\\mathrm{E2}} = \\frac{\\frac{\\left[\\mathrm{E2}\\right]}{K_{d,\\mathrm{E2}}}}{1 + \\frac{\\left[\\mathrm{E2}\\right]}{K_{d,\\mathrm{E2}}} + \\frac{\\left[\\mathrm{BPA}\\right]}{K_{d,\\mathrm{BPA}}}}$$\n\nFor BPA, it is:\n$$f_{\\mathrm{BPA}} = \\frac{\\frac{\\left[\\mathrm{BPA}\\right]}{K_{d,\\mathrm{BPA}}}}{1 + \\frac{\\left[\\mathrm{E2}\\right]}{K_{d,\\mathrm{E2}}} + \\frac{\\left[\\mathrm{BPA}\\right]}{K_{d,\\mathrm{BPA}}}}$$\n\nNow we proceed to the numerical calculation using the provided parameters:\n- $K_{d,\\mathrm{E2}} = 0.2$ nM\n- $K_{d,\\mathrm{BPA}} = 2$ nM\n- $\\left[\\mathrm{E2}\\right] = 0.1$ nM\n- $\\left[\\mathrm{BPA}\\right] = 10$ nM\n\nFirst, we calculate the dimensionless concentration terms, which represent the ligand concentrations normalized by their respective dissociation constants:\n$$\\frac{\\left[\\mathrm{E2}\\right]}{K_{d,\\mathrm{E2}}} = \\frac{0.1 \\text{ nM}}{0.2 \\text{ nM}} = 0.5$$\n$$\\frac{\\left[\\mathrm{BPA}\\right]}{K_{d,\\mathrm{BPA}}} = \\frac{10 \\text{ nM}}{2 \\text{ nM}} = 5$$\n\nNext, we calculate the denominator of the fractional occupancy expressions, which is common to both:\n$$D = 1 + \\frac{\\left[\\mathrm{E2}\\right]}{K_{d,\\mathrm{E2}}} + \\frac{\\left[\\mathrm{BPA}\\right]}{K_{d,\\mathrm{BPA}}} = 1 + 0.5 + 5 = 6.5$$\n\nNow, we can compute the fractional occupancy for each ligand.\nFor E2:\n$$f_{\\mathrm{E2}} = \\frac{0.5}{6.5} = \\frac{5}{65} = \\frac{1}{13} \\approx 0.07692307...$$\nRounding to four significant figures gives $f_{\\mathrm{E2}} = 0.07692$.\n\nFor BPA:\n$$f_{\\mathrm{BPA}} = \\frac{5}{6.5} = \\frac{50}{65} = \\frac{10}{13} \\approx 0.7692307...$$\nRounding to four significant figures gives $f_{\\mathrm{BPA}} = 0.7692$.\n\nIt is instructive to note that despite the significantly lower concentration of BPA relative to its affinity ($\\frac{[\\mathrm{BPA}]}{K_{d,\\mathrm{BPA}}} = 5$) compared to E2 relative to its affinity ($\\frac{[\\mathrm{E2}]}{K_{d,\\mathrm{E2}}} = 0.5$), the high absolute concentration of BPA ($100$-fold that of E2) leads to BPA occupying a much larger fraction of the available receptors. Specifically, BPA occupies approximately $10$ times more receptors than the endogenous ligand E2 under these conditions.\nThe total fractional occupancy is $f_{\\mathrm{E2}} + f_{\\mathrm{BPA}} = \\frac{1}{13} + \\frac{10}{13} = \\frac{11}{13} \\approx 0.8462$. The remaining fraction of receptors, $\\frac{2}{13} \\approx 0.1538$, are unbound.\n\nThe computed values for $f_{\\mathrm{E2}}$ and $f_{\\mathrm{BPA}}$ are $0.07692$ and $0.7692$, respectively.", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n0.07692 & 0.7692\n\\end{pmatrix}\n}\n$$", "id": "2633708"}, {"introduction": "Endocrine disruption can occur at multiple levels, including the synthesis of hormones. This practice focuses on the enzymatic pathways responsible for producing steroid hormones, such as the conversion of androgens to estrogens by aromatase. Using the Michaelis–Menten framework, you will model how an endocrine-disrupting chemical that reduces the amount of a key enzyme can directly impact the rate of hormone production, demonstrating a crucial mechanism of endocrine disruption upstream of the receptor.", "problem": "Aromatase (cytochrome P450 family 19 subfamily A member 1, CYP19A1) catalyzes the final step in estradiol biosynthesis in ovarian granulosa cells by converting androgens to estrogens. Consider an endocrine-disrupting chemical (EDC) that downregulates CYP19A1 protein abundance without altering its catalytic turnover number or substrate affinity. Assume steady-state Michaelis–Menten conditions for a single-substrate reaction hold for CYP19A1 acting on its androgen substrate, with the rate given by $v=\\frac{V_{\\max}[S]}{K_m+[S]}$, where $V_{\\max}=k_{\\text{cat}}E_{\\text{tot}}$, $k_{\\text{cat}}$ is the catalytic turnover number, and $E_{\\text{tot}}$ is the total enzyme concentration. Experimental measurements indicate that under control conditions the substrate concentration satisfies $[S]=2K_m$. After EDC exposure, $E_{\\text{tot}}$ is reduced by $50\\%$, while $k_{\\text{cat}}$ and $K_m$ remain unchanged.\n\nUsing only the definitions above and the Michaelis–Menten framework, derive from first principles the fold-change in estradiol synthesis rate, defined as $F=\\frac{v_{\\text{EDC}}}{v_{\\text{control}}}$, at $[S]=2K_m$. Provide your final answer as a single simplified fraction (dimensionless). Do not round.", "solution": "The problem as stated is scientifically grounded, well-posed, and contains sufficient information for a unique solution. It is a valid problem in enzyme kinetics applied to developmental biology. We proceed with the derivation.\n\nThe fundamental relationship governing the rate of the enzymatic reaction is the Michaelis–Menten equation:\n$$v = \\frac{V_{\\max}[S]}{K_m + [S]}$$\nwhere $v$ is the reaction rate, $[S]$ is the substrate concentration, $K_m$ is the Michaelis constant, and $V_{\\max}$ is the maximum reaction rate.\n\nThe problem states that $V_{\\max}$ is defined as the product of the catalytic turnover number, $k_{\\text{cat}}$, and the total enzyme concentration, $E_{\\text{tot}}$.\n$$V_{\\max} = k_{\\text{cat}}E_{\\text{tot}}$$\nSubstituting this definition into the Michaelis–Menten equation gives the reaction rate in terms of the total enzyme concentration:\n$$v = \\frac{k_{\\text{cat}}E_{\\text{tot}}[S]}{K_m + [S]}$$\n\nWe are asked to find the fold-change $F$, defined as the ratio of the reaction rate under exposure to the endocrine-disrupting chemical (EDC), $v_{\\text{EDC}}$, to the rate under control conditions, $v_{\\text{control}}$.\n$$F = \\frac{v_{\\text{EDC}}}{v_{\\text{control}}}$$\n\nLet us denote the total enzyme concentration under control conditions as $E_{\\text{tot, control}}$. The corresponding reaction rate, $v_{\\text{control}}$, is given by:\n$$v_{\\text{control}} = \\frac{k_{\\text{cat}}E_{\\text{tot, control}}[S]}{K_m + [S]}$$\n\nThe problem states that exposure to the EDC reduces the total enzyme concentration by $50\\%$. Therefore, the enzyme concentration under EDC exposure, $E_{\\text{tot, EDC}}$, is:\n$$E_{\\text{tot, EDC}} = (1 - 0.5) E_{\\text{tot, control}} = \\frac{1}{2} E_{\\text{tot, control}}$$\nThe parameters $k_{\\text{cat}}$ and $K_m$ are stated to be unchanged. The corresponding reaction rate, $v_{\\text{EDC}}$, is:\n$$v_{\\text{EDC}} = \\frac{k_{\\text{cat}}E_{\\text{tot, EDC}}[S]}{K_m + [S]} = \\frac{k_{\\text{cat}}\\left(\\frac{1}{2} E_{\\text{tot, control}}\\right)[S]}{K_m + [S]}$$\n\nNow, we construct the ratio for the fold-change, $F$:\n$$F = \\frac{v_{\\text{EDC}}}{v_{\\text{control}}} = \\frac{\\frac{k_{\\text{cat}}\\left(\\frac{1}{2} E_{\\text{tot, control}}\\right)[S]}{K_m + [S]}}{\\frac{k_{\\text{cat}}E_{\\text{tot, control}}[S]}{K_m + [S]}}$$\nThe terms $k_{\\text{cat}}$, $E_{\\text{tot, control}}$, $[S]$, and $(K_m+[S])$ are present in both the numerator and the denominator. Since the reaction is occurring, these terms are non-zero and can be cancelled.\n$$F = \\frac{\\frac{1}{2}}{1} = \\frac{1}{2}$$\nThis result demonstrates that the fold-change in reaction rate is directly proportional to the fold-change in total enzyme concentration, provided all other parameters ($k_{\\text{cat}}$, $K_m$) and conditions ($[S]$) are held constant between the two measurements.\n\nThe problem specifies that the analysis is to be performed at a substrate concentration of $[S] = 2K_m$. While our derivation shows that the fold-change $F$ is independent of the specific substrate concentration, we can verify the result for this specific condition to confirm our logic.\n\nFor the control condition at $[S] = 2K_m$:\n$$v_{\\text{control}} = \\frac{k_{\\text{cat}}E_{\\text{tot, control}}(2K_m)}{K_m + 2K_m} = \\frac{k_{\\text{cat}}E_{\\text{tot, control}}(2K_m)}{3K_m} = \\frac{2}{3}k_{\\text{cat}}E_{\\text{tot, control}}$$\nFor the EDC-exposed condition at $[S] = 2K_m$:\n$$v_{\\text{EDC}} = \\frac{k_{\\text{cat}}\\left(\\frac{1}{2}E_{\\text{tot, control}}\\right)(2K_m)}{K_m + 2K_m} = \\frac{k_{\\text{cat}}\\left(\\frac{1}{2}E_{\\text{tot, control}}\\right)(2K_m)}{3K_m} = \\frac{1}{3}k_{\\text{cat}}E_{\\text{tot, control}}$$\nThe ratio is then:\n$$F = \\frac{v_{\\text{EDC}}}{v_{\\text{control}}} = \\frac{\\frac{1}{3}k_{\\text{cat}}E_{\\text{tot, control}}}{\\frac{2}{3}k_{\\text{cat}}E_{\\text{tot, control}}} = \\frac{1/3}{2/3} = \\frac{1}{2}$$\nThis confirms the result derived from first principles. The fold-change in estradiol synthesis rate is $\\frac{1}{2}$.", "answer": "$$\\boxed{\\frac{1}{2}}$$", "id": "2633690"}, {"introduction": "In the real world, organisms are exposed to mixtures of chemicals, not single substances. This practice introduces a foundational tool in mixture toxicology: the principle of dose addition for chemicals that share a common mechanism of action. By calculating a toxic equivalency, you will learn to quantify the combined effect of a multi-component exposure, a critical skill for translating mechanistic understanding into a realistic risk assessment.", "problem": "In mixture toxicology for chemicals that act through a common mode of action on a single signaling axis, the principle of dose addition is a well-tested starting point. Consider two antiandrogenic chemicals, A and B, that both antagonize the androgen receptor (AR). Let the fractional response (e.g., inhibition of AR-driven transcription) for each chemical as a function of administered dose be represented by monotonic dose–response functions $f_A(d)$ and $f_B(d)$, respectively. For any fixed effect level $y \\in (0,1)$, define the equipotent doses $d_A(y)$ and $d_B(y)$ by $f_A(d_A(y))=y$ and $f_B(d_B(y))=y$, and define the relative potency factor (RPF) of chemical B relative to chemical A at that effect level by $\\rho_{B \\to A}(y) = \\dfrac{d_A(y)}{d_B(y)}$. When the two chemicals share a common mechanism and have parallel dose–response functions over the relevant range (e.g., similar Hill slope and efficacy), it is appropriate to treat $\\rho_{B \\to A}(y)$ as approximately constant across $y$ in that range, denoted simply by $\\rho_{B \\to A}$, and to use dose addition by converting B’s dose into A-equivalents via this RPF.\n\nUsing only these definitions and the dose-addition principle, derive the algebraic expression for the A-equivalent dose, $D_A^{\\mathrm{eq}}$, of a binary mixture receiving doses $D_A$ of A and $D_B$ of B in terms of $D_A$, $D_B$, and $\\rho_{B \\to A}$. Then apply it to the following scientifically plausible scenario: chemical B is reported to be $0.1$ times the potency of chemical A for AR antagonism (i.e., $\\rho_{B \\to A}=0.1$), and an organism is co-exposed to $D_A = 10\\,\\mu\\mathrm{g}/\\mathrm{kg}$ of A and $D_B = 50\\,\\mu\\mathrm{g}/\\mathrm{kg}$ of B.\n\nCompute the numerical value of $D_A^{\\mathrm{eq}}$ for this mixture. Express your final answer in $\\mu\\mathrm{g}/\\mathrm{kg}$. No rounding is required; report the exact value.", "solution": "The problem as stated is subjected to validation and is found to be valid. It is scientifically grounded in the principles of mixture toxicology, specifically the concept of dose addition for chemicals with a common mode of action. The definitions provided for dose-response functions, equipotent doses, and the relative potency factor (RPF) are standard and correctly formulated. The problem is well-posed, with all necessary information provided to derive the required expression and compute the numerical result. There are no logical contradictions, factual errors, or ambiguities.\n\nThe task is to first derive the algebraic expression for the A-equivalent dose, $D_A^{\\mathrm{eq}}$, of a binary mixture and then to apply this expression to a specific scenario.\n\nThe fundamental principle is dose addition. For a mixture of chemicals acting via the same mechanism, the total effect is predicted based on the sum of the doses of the components, where each dose is expressed in terms of an equivalent dose of a common reference chemical. Here, chemical A is the reference chemical.\n\nThe total A-equivalent dose, $D_A^{\\mathrm{eq}}$, is the sum of the dose of chemical A and the A-equivalent dose of chemical B. The mixture contains a dose $D_A$ of chemical A, which is by definition its own contribution to the A-equivalent total.\nThe mixture also contains a dose $D_B$ of chemical B. We must convert this dose into its A-equivalent value.\n\nThe relative potency factor of B with respect to A, $\\rho_{B \\to A}$, is defined based on equipotent doses $d_A(y)$ and $d_B(y)$ that produce an identical effect level $y$:\n$$ \\rho_{B \\to A} = \\frac{d_A(y)}{d_B(y)} $$\nThe problem states that this ratio is constant over the relevant range of effects. This relationship implies that a dose $d_B(y)$ of chemical B is equivalent in its biological effect to a dose $d_A(y) = \\rho_{B \\to A} \\cdot d_B(y)$ of chemical A.\nThis scaling applies to any dose. Therefore, a given dose $D_B$ of chemical B has an A-equivalent dose given by the product of $D_B$ and the relative potency factor $\\rho_{B \\to A}$.\nContribution of B in A-equivalents $= \\rho_{B \\to A} D_B$.\n\nAccording to the principle of dose addition, the total A-equivalent dose of the mixture, $D_A^{\\mathrm{eq}}$, is the linear sum of the dose of A and the A-equivalent dose of B:\n$$ D_A^{\\mathrm{eq}} = D_A + \\rho_{B \\to A} D_B $$\nThis is the required general algebraic expression.\n\nNow, we apply this formula to the specific scenario provided. The given values are:\nThe dose of chemical A, $D_A = 10\\,\\mu\\mathrm{g}/\\mathrm{kg}$.\nThe dose of chemical B, $D_B = 50\\,\\mu\\mathrm{g}/\\mathrm{kg}$.\nThe relative potency factor, $\\rho_{B \\to A} = 0.1$.\n\nSubstituting these values into the derived expression:\n$$ D_A^{\\mathrm{eq}} = 10 + (0.1) \\cdot (50) $$\nWe perform the calculation:\n$$ D_A^{\\mathrm{eq}} = 10 + 5 $$\n$$ D_A^{\\mathrm{eq}} = 15 $$\nThe resulting A-equivalent dose is $15\\,\\mu\\mathrm{g}/\\mathrm{kg}$. This represents the dose of chemical A that would be required to produce the same level of androgen receptor antagonism as the mixture of $10\\,\\mu\\mathrm{g}/\\mathrm{kg}$ of A and $50\\,\\mu\\mathrm{g}/\\mathrm{kg}$ of B.", "answer": "$$\\boxed{15}$$", "id": "2633588"}]}